Nov 10, 2014
The pharma companies have a significant opportunity for Ebola virus infection drugs and vaccines, expected to be priced at a premium.
Sep 04, 2014
An essential resource of market intelligence, expert analyses and strategic insights for industry executives and decision-makers. Includes supplier shares, and country forecasts for 400 assays, 20 market segments and 14 test locations worldwide.
Jul 25, 2014
This study is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies in testing for genetic diseases, cancer, forensic and paternity/HLA applications.
Jul 22, 2014
Sales and market shares of leading suppliers of infectious disease molecular diagnostic reagent kits and components. Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic assays.
Jul 22, 2014
Emerging trends in the US, Europe and Asia; supplier shares and forecasts for 100 procedures by market segment and country; innovative technologies and instrumentation review; competitive insights; opportunities for instrument and reagent suppliers.
Jul 17, 2014
Emerging trends in the US, Europe and Asia; supplier shares and forecasts for 40 procedures by market segment and country; innovative technologies and instrumentation review; competitive insights; opportunities for instrument and reagent suppliers.
Jul 16, 2014
A new comprehensive seven-country report designed to assist diagnostics industry executives, as well as companies planning to diversify into the rapidly expanding hematology and flow cytometry markets in evaluating emerging opportunities.
Jul 15, 2014
A new global analysis of the Cancer Diagnostics Market opportunities, emerging trends, innovative technologies, and competitive landscape.
Jul 14, 2014
A new comprehensive seven-country report designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology testing market in evaluating emerging opportunities.
Jul 14, 2014
-Will the diagnostics industry consolidate, decentralize, or undergo bimodal transformation? -How will future reimbursement changes affect individual market segments? -How will future technological advances affect the major market segment?